These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 34099630)

  • 1. Recent progress in targeted delivery vectors based on biomimetic nanoparticles.
    Chen L; Hong W; Ren W; Xu T; Qian Z; He Z
    Signal Transduct Target Ther; 2021 Jun; 6(1):225. PubMed ID: 34099630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Targeting Drug Biological Carriers for Enhancing Tumor Therapy Efficacy.
    Xia D; Li J; Feng L; Gao Z; Liu J; Wang X; Hu Y
    Macromol Biosci; 2023 Dec; 23(12):e2300178. PubMed ID: 37466216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles.
    Li A; Zhao Y; Li Y; Jiang L; Gu Y; Liu J
    Drug Deliv; 2021 Dec; 28(1):1237-1255. PubMed ID: 34142930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomimetic nanoarchitecturing: A disguised attack on cancer cells.
    Jha A; Nikam AN; Kulkarni S; Mutalik SP; Pandey A; Hegde M; Rao BSS; Mutalik S
    J Control Release; 2021 Jan; 329():413-433. PubMed ID: 33301837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles as an Efficient and Versatile System for Drug Delivery.
    Dang XTT; Kavishka JM; Zhang DX; Pirisinu M; Le MTN
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered Extracellular Vesicles for Cancer Therapy.
    Zhang X; Zhang H; Gu J; Zhang J; Shi H; Qian H; Wang D; Xu W; Pan J; Santos HA
    Adv Mater; 2021 Apr; 33(14):e2005709. PubMed ID: 33644908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid Membrane-Coated Biomimetic Nanoparticles (HM@BNPs): A Multifunctional Nanomaterial for Biomedical Applications.
    Zhao Y; Li A; Jiang L; Gu Y; Liu J
    Biomacromolecules; 2021 Aug; 22(8):3149-3167. PubMed ID: 34225451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
    Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
    Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Assembly of Extracellular Vesicle-like Metal-Organic Framework Nanoparticles for Protection and Intracellular Delivery of Biofunctional Proteins.
    Cheng G; Li W; Ha L; Han X; Hao S; Wan Y; Wang Z; Dong F; Zou X; Mao Y; Zheng SY
    J Am Chem Soc; 2018 Jun; 140(23):7282-7291. PubMed ID: 29809001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomimetic particles as therapeutics.
    Meyer RA; Sunshine JC; Green JJ
    Trends Biotechnol; 2015 Sep; 33(9):514-524. PubMed ID: 26277289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell membrane-based biomimetic vehicles for effective central nervous system target delivery: Insights and challenges.
    Wu H; Zhang T; Li N; Gao J
    J Control Release; 2023 Aug; 360():169-184. PubMed ID: 37343724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification.
    Liu Q; Li D; Pan X; Liang Y
    J Nanobiotechnology; 2023 Sep; 21(1):334. PubMed ID: 37717008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards protein-based viral mimetics for cancer therapies.
    Unzueta U; Céspedes MV; Vázquez E; Ferrer-Miralles N; Mangues R; Villaverde A
    Trends Biotechnol; 2015 May; 33(5):253-8. PubMed ID: 25805413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered extracellular vesicles-like biomimetic nanoparticles as an emerging platform for targeted cancer therapy.
    Liu X; Xiao C; Xiao K
    J Nanobiotechnology; 2023 Aug; 21(1):287. PubMed ID: 37608298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances on extracellular vesicles in therapeutic delivery: Challenges, solutions, and opportunities.
    Lu M; Xing H; Yang Z; Sun Y; Yang T; Zhao X; Cai C; Wang D; Ding P
    Eur J Pharm Biopharm; 2017 Oct; 119():381-395. PubMed ID: 28739288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicines in oral cancer: inspiration comes from extracellular vesicles and biomimetic nanoparticles.
    Bai YT; Zhang XQ; Chen XJ; Zhou G
    Nanomedicine (Lond); 2022 Oct; 17(23):1761-1778. PubMed ID: 36647844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research Progress in Bioinspired Drug Delivery Systems.
    Tong Q; Qiu N; Ji J; Ye L; Zhai G
    Expert Opin Drug Deliv; 2020 Sep; 17(9):1269-1288. PubMed ID: 32543953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug delivery to the eye: what benefits do nanocarriers offer?
    Joseph RR; Venkatraman SS
    Nanomedicine (Lond); 2017 Mar; 12(6):683-702. PubMed ID: 28186436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.